Bioptimus, a Paris, France-based biotechnology company providing an AI foundation model for the research, raised $35M in funding.
The round was led by Sofinnova Partners, and Bpifrance Large Venture, with participation from Frst, Cathay Innovation, Headline, Hummingbird, NJF Capital, Owkin and Top Harvest Capital, as well as tech entrepreneur Xavier Niel.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Jean-Philippe Vert, Bioptimus is building a universal AI foundation model in biology to drive advancements in scientific research and biotechnological innovation. The company will connect the different scales of biology with generative AI, from molecules to cells, tissues and whole organisms, to accelerate scientific breakthroughs and accelerate innovation in biomedicine and beyond.
Commenting on the news, Jean-Philippe Vert said: “The application of foundation models and generative AI to biology is set to have a profound impact in science. By harnessing the power of foundation models and advanced algorithms trained on massive amounts of biological and multimodal data across scales, we aim to capture the laws of biology that have hitherto remained too complex to be properly understood. This holistic understanding of biology across scales will be critical to accelerate biomedical and environmental science.”
FinSMEs
20/02/2024